Showing results (51-60 of 171) with videos related to
Sort By:
Pageof 18
The Journal of Urology|December 13, 2006
Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?Harry W Herr, S Machele Donat, Guido DalbagniJournal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
The integration of chemotherapy and surgery for bladder cancerMatthew D Galsky, Harry W Herr, Dean E BajorinJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factorsFarhang Rabbani, Harry W Herr, Taghreed Almahmeed, et al.The Journal of Urology|August 19, 2007
Management of low grade papillary bladder tumorsHarry W Herr, S Machele Donat, Victor E ReuterThe Journal of Urology|January 10, 2004
Efficacy of office fulguration for recurrent low grade papillary bladder tumors less than 0.5 cmS Machele Donat, Amanda North, Guido Dalbagni, et al.The Journal of Urology|October 9, 2003
Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancerS Machele Donat, Sharon Bayuga, Harry W Herr, et al.BJU International|March 30, 2010
Bladder cancer in cystoscopically normal-appearing mucosa: a case of mistaken identity?Harry W Herr, Hikmat Al-Ahmadie, Guido Dalbagni, et al.Urologic Oncology|April 17, 2017
Regionalization of radical cystectomy in the United StatesChristopher B Anderson, Renee Gennarelli, Harry W Herr, et al.The Journal of Urology|January 16, 2007
Defining optimal therapy for muscle invasive bladder cancerHarry W Herr, Zohar Dotan, S Machele Donat, et al.European Urology|January 25, 2011
Maximizing cure for muscle-invasive bladder cancer: integration of surgery and chemotherapyAndrew H Feifer, Jennifer M Taylor, Tatum V Tarin, et al.Pageof 18